Abstract:
Disclosed herein is a process for the preparation of erythromycin derivatives, or pharmaceutically acceptable salts thereof, which contain an optionally substituted propargyl group at the 6-O-position.
Abstract:
Methods and novel intermediates for the preparation of acyclic nucleoside derivatives of formula (I) where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a -C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
Abstract:
Disclosed herein is a process for the preparation of erythromycin derivative s, or pharmaceutically acceptable salts thereof, which contain an optionally substituted propargyl group at the 6-O-position.
Abstract:
Se describe un proceso para hacer (2S,5R)-5-etinil-1-{N-(4-metil-1 -(4-carboxi-piridin-2-il)piperidin-4-il)glicil}pirrolidina-2-carb onitrilo y sales del mismo, y los intermediarios usados en el proceso.
Abstract:
Disclosed herein is a process for the preparation of erythromycin derivative s, or pharmaceutically acceptable salts thereof, which contain an optionally substituted propargyl group at the 6-O- position.
Abstract:
A process for making (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridi n-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile and salts thereof, a nd intermediates used in the process are disclosed.